Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans. [PDF]
Hannachi E +9 more
europepmc +1 more source
Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]
Gnann DC +3 more
europepmc +1 more source
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology. [PDF]
Bayer AC +16 more
europepmc +1 more source
mRNA-Encoded Antibodies: An Emerging Paradigm in Antiviral Protection. [PDF]
Klotchenko S, Plotnikova M.
europepmc +1 more source
Identification of PD-1-PD-L1 blockade epitopes in vitro utilizing porcine immunoglobulin and heterologous Fc-fused protein. [PDF]
Dong Y +7 more
europepmc +1 more source
Phase Ia study to evaluate RO7497987, a FLT3L-fragment Fc fusion protein, in healthy volunteers. [PDF]
Iacovelli AJ +9 more
europepmc +1 more source
Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1. [PDF]
Klingler J +12 more
europepmc +1 more source
A Molecular Basis for Antibody Specificity Crystal Structures of IgE-Allergen and IgG-Hapten Complexes [PDF]
Niemi, Merja
core
Related searches:
Impairment by glycation of immunoglobulin G Fc fragment function
Scandinavian Journal of Clinical and Laboratory Investigation, 1990Incubation of human immunoglobulin G (IgG) with glucose in vitro leads to the formation of glycated IgG concomitant with marked changes in functional properties of the Fc fragment. After 22 days of incubation in the absence and presence of 13.9, 27.7 and 55.5 mmol/l glucose, respectively, protein A binding was reduced by 42, 66 and 83%, depending on ...
R, Dolhofer-Bliesener, K D, Gerbitz
openaire +2 more sources

